Sanara MedTech Inc.
For the period ended Dec 31, 2025. Filed Mar 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 24, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. FORM 10-K SUMMARY
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SANARA MEDTECH INC. | ||
| March 24, 2026 | By: | /s/ Elizabeth B. Taylor |
|---|---|---|
| Elizabeth B. Taylor | ||
| Chief Financial Officer | ||
| (Principal Financial Officer and duly authorized officer) | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Seth D. Yon | President, Chief Executive Officer and Director (Principal Executive Officer) | March 24, 2026 |
| Seth D. Yon | ||
| /s/ Elizabeth B. Taylor | Chief Financial Officer (Principal Financial Officer) | March 24, 2026 |
| Elizabeth B. Taylor | ||
| /s/ Ashley M. Mackey | Controller (Principal Accounting Officer) | March 24, 2026 |
| Ashley M. Mackey | ||
| /s/ Ronald T. Nixon | Chairman | March 24, 2026 |
| Ronald T. Nixon | ||
| /s/ Robert DeSutter | Director | March 24, 2026 |
| Robert DeSutter | ||
| /s/ Roszell Mack III | Director | March 24, 2026 |
| Roszell Mack III | ||
| /s/ Eric D. Major | Director | March 24, 2026 |
| Eric D. Major | ||
| /s/ Sara Ortwein | Director | March 24, 2026 |
| Sara Ortwein | ||
| /s/ Ann Beal Salamone | Director | March 24, 2026 |
| Ann Beal Salamone | ||
| /s/ Keith G. Myers | Director | March 24, 2026 |
| Keith G. Myers | ||
| /s/ Eric D. Tanzberger | Director | March 24, 2026 |
| Eric D. Tanzberger | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.